First-in-human study of the safety, pharmacokinetics, and

NIA-Funded Active Alzheimer's and Related Dementias Clinical

Mean (SD) enpatoran plasma concentration‐time profiles following single

Expression and clinical significance of ECHS1 in gastric cancer

Frontiers The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures

Phase I and first-in-human Clinical Trials and FDA's CGMP Requirements

IND-Enabling Studies

PDF) Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8

Biomolecules, Free Full-Text

The role of lipids in cancer progression and metastasis - ScienceDirect